Monod Bio

🎉 It's Here! 🎉 We are excited to announce the release of our first product, LuxSit™ Pro, the world's first fully de novo luciferase and for the first fully de novo protein to reach the commercial market. LuxSit™ Pro is small, hyperstable, and available in both full length and split formats. Have a look at today's press release: https://lnkd.in/gA-8RKWp and visit us here to order LuxSit™ Pro: https://lnkd.in/ggvUeMMC #productlaunch #denovoprotein #proteindesign #monodbio #LuxSitPro #luciferase

🎉 It's Here! 🎉 We are excited to announce the release of our first product, LuxSit™ Pro, the world's first fully de novo luciferase and for the first fully de novo protein to reach the commercial market. LuxSit™ Pro is small, hyperstable, and available in both full length and split formats. Have a look at today's press release: https://lnkd.in/gA-8RKWp and visit us here to order LuxSit™ Pro: https://lnkd.in/ggvUeMMC #productlaunch #denovoprotein #proteindesign #monodbio #LuxSitPro #luciferase

We've got an exciting announcement on Monday...

Happy 4th of July! 🌟 At Monod Bio, we're wishing everyone a safe and joyful holiday filled with celebration and reflection. Happy Independence Day! #IndependenceDay #4thOfJuly #Celebrate #MonodBio

We're thrilled to be part of hosting the OUTbio Seattle Pride Party at Dexter Yard tomorrow! Join us for stunning rooftop views along with delicious food & beverages. Happy Pride! 🌈 #SeattlePride #biotech #PrideMonth

Congratulations to Élyse Fischer!🚴♀️ We're thrilled to announce that Élyse Fischer has won BioMed Realty's annual May Bike Month Challenge here at Dexter Yard... for the second year in a row! 🎉 We're incredibly proud to see our talented staff being recognized outside of the lab. Keep pedaling, Élyse! #BikeMonth #BMRChallenge #CyclingChampion #GoElyse

We are delighted to announce that our advisor, Gonçalo Bernardes, PhD, has been honored with the 2024 Corday-Morgan Mid-Career Prize for Chemistry by the Royal Society of Chemistry. This prestigious award highlights Dr. Bernardes' dedication and groundbreaking work in targeted therapeutics, including small molecule-based RNA degradation, at the University of Cambridge. Congratulations, Dr. Bernardes, on this well-deserved recognition! Link: https://lnkd.in/ejxRWH-u

At #BIO2024, our CEO and Co-Founder, Daniel-Adriano S., PhD, spoke at the AI's Impact on Oncology Cancer Drug Development panel along with other CEOs. During the panel, he discussed the relevance of our technology to the development of companion diagnostics. Additionally, he and the other panelists discussed AI's impact in the next 2, 5, and 10 years. #artificialintelligence #AI #biotech

And that's a wrap to #BIO2024! We were thrilled to see that BIO 2024 was bustling, well-attended, and very productive. This year two of our founders, CEO, Daniel-Adriano S., PhD, and COO, David Shoultz, PhD, MBA, were able to participate. In addition, our Senior Director of Business Development & Commercialization, Matthew Brown, MBA, was in attendance to lead our business development and commercialization efforts. We were pleased to engage in multiple meetings with potential commercial partners and investors, along with the opportunity to meet with select academic partners. #biotech #SanDiego

Join us at the Technology Alliance's Seattle AI Investment Summit + Showcase on June 10-11! Our COO and Co-Founder, David Shoultz, PhD, MBA, will be presenting during the Startup Showcase. We're thrilled to explore the incredible impacts of #AI technology on the #biotech ecosystem and share our role in this innovation. #Seattle #Startup #ArtificialIntelligence Event details: https://lnkd.in/gvzcVB2u